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Y-box protein (YB)-1 of the cold-shock protein family functions
in gene transcription and RNA processing. Extracellular functions
have not been reported, but the YB-1 staining pattern in
inflammatory glomerular diseases, without adherence to cell
boundaries, suggests an extracellular occurrence. Here, we show
the secretion of YB-1 by mesangial and monocytic cells after
inflammatory challenges. It should be noted that YB-1 was
secreted through a non-classical mode resembling that of the
macrophage migration inhibitory factor. YB-1 release requires
ATP-binding cassette transporters, and microvesicles protect
YB-1 from protease degradation. Two lysine residues in the
YB-1 carboxy-terminal domain are crucial for its release,
probably because of post-translational modifications. The
addition of purified recombinant YB-1 protein to different cell
types results in increased DNA synthesis, cell proliferation and
migration. Thus, the non-classically secreted YB-1 has extra-
cellular functions and exerts mitogenic as well as promigratory
effects in inflammation.
Keywords: cold shock protein; YB-1; non-classical secretion;
inflammation; microvesicles
EMBO reports (2009) 10, 783–789. doi:10.1038/embor.2009.81
INTRODUCTION
For several protein families involved in nucleotide processing,
an extraordinary level of evolutionary conservation has been
described. Their nuclear functions relate to the orchestration of
transcription and modulation of DNA structures. For some of these
proteins, extracellular occurrence and functions were identified;
for example, heat-shock and high-mobility-group box (HMGB)
proteins are secreted in inflammatory diseases (Bianchi &
Manfredi, 2007). A pathophysiological relevance of extracellular
HMGB1 in inflammatory diseases has been shown in sepsis,
ischaemia reperfusion damage and atherosclerosis, with
antibody-mediated HMGB1 neutralization having a protective
role (Bianchi & Manfredi, 2007).
Y-box protein (YB)-1 is prototypic for the highly conserved,
so-called, cold-shock protein family. It regulates gene transcrip-
tion and RNA processing/translation together with other factors
(Kohno et al, 2003; Raffetseder et al, 2003; Evdokimova et al,
2006). YB-1 protein attracted our interest because of its pro- as
well as anti-inflammatory functions (Inagaki et al, 2005; Dooley
et al, 2006). In experimental mesangioproliferative nephritis, YB-1
localization changes from nuclear to cytoplasmic in diseased
animals, with the YB-1 staining pattern exceeding cellular
boundaries (van Roeyen et al, 2005). This led us to propose an
extracellular occurrence for YB-1 under inflammatory conditions.
RESULTS AND DISCUSSION
Monocytic cells secrete YB-1 on LPS incubation
In an experimental model of acute kidney-transplant rejection
(Kunter et al, 2003), ED1-positive monocytes and macrophages
showed a high level of YB-1 expression (Fig 1A). Given the
missing confinement of YB-1 to cell boundaries in mesangiopro-
liferative disease (van Roeyen et al, 2005) and its strong expression
by mononuclear cells, we suggested that YB-1 secretion might
have occurred. Secretion of a nuclear protein seems unexpected at
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783first; however, such a process is not unprecedented, given the
secretion of transcription factor HMGB1 in inflammation, a
protein with similar evolutionary conservation.
Primary human monocytes were exposed to increasing
lipopolysaccharide (LPS) concentrations for 4h and the
supernatants were trichloroacetic acid (TCA)-precipitated.
Immunoblotting showed dose-dependent secretion of YB-1, which
peaked at a concentration of 5ng/ml LPS (Fig 1B), whereas no
non-specific cytosolic protein release, for example that of
glyceraldehyde 3-phosphate dehydrogenase, was observed. A
Trypan-blue exclusion assay confirmed that protein release was
not due to a lack of cell integrity (viability 495%). By contrast,
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Fig 1 |Lipopolysaccharide induces YB-1 secretion in primary monocytic cells. (A) In acute kidney-transplant rejection, infiltrating monocytes are
double immunopositive for YB-1 and ED1. The inset (left panel) shows immunohistochemical analyses carried out with healthy kidney. (B) LPS
stimulation of primary monocytes leads to a concentration-dependent release of YB-1 into the supernatant. Detection was carried out with
TCA-precipitated conditioned medium, (C) and quantified to 25% of the total cellular YB-1 content at maximum. (D) Macrophage migration
inhibitory factor concentration in the supernatant is increased in a similar LPS concentration range. (E) LPS stimulation of monocytes with
subsequent vesicle preparation (see supplementary Fig 2 online) enriches YB-1 protein. Vesicles successfully protect YB-1 against protease activity
(trypsin, second panel). Detergent pretreatment (Triton X-100, third panel) disrupts vesicles and trypsin degrades YB-1. Spill-over of cytoplasmic
protein is excluded by glyceraldehyde 3-phosphate dehydrogenase detection (fourth panel) and proper vesicle preparation is verified by the presence
of RAB7 (fifth panel). YB-1 was also detected in TCA-precipitated medium after removal of vesicular structures by centrifugation (sixth panel). Control
for total cellular protein and intracellular RAB7 content is given in the lowest panel. CON, control; LPS, lipopolysaccharide; MIF, macrophage
migration inhibitory factor; TCA, trichloroacetic acid; w/o, without; YB, Y-box protein.
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784intracellular YB-1 protein levels essentially did not change after
LPS exposure (Fig 2B, lower panel). Calculation of protein loading
and band intensities indicated that approximately 25% of total
YB-1 protein was secreted by primary monocytes on stimulation,
using 5ng/ml LPS (Fig 1C). Quantification of macrophage
migration inhibitory factor (MIF; Kleemann et al, 2000) in the
same supernatant by ELISA indicated a similar dose response
to LPS (Fig 1D). LPS-induced secretion of both YB-1 and MIF
was also observed in MonoMac-6 (MM6) cells (supplementary
Fig 1B–D online), underpinning the above findings. MM6 cells are
well-characterized LPS-responsive monocytic cells. In this system,
YB-1 secretion was also apparent in a narrow LPS concentration
range between 1 and 7.5ng/ml, which paralleled MIF secretion
(supplementary Fig 1B,C online). Kinetic studies carried out at the
peak LPS concentration of 5ng/ml showed low-level baseline
secretion of YB-1 up to 2h, followed by an apparent marked LPS
effect after 4h (supplementary Fig 1D online).
On the basis of earlier observations made for HMGB1
(Gardella et al, 2002), we addressed the possibility whether
vesicles are involved in YB-1 release. Vesicles were prepared
from supernatants on cell stimulation with LPS (supplementary
Fig 2A online). Indeed, vesicle-enriched fractions contained YB-1
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Fig 2 |YB-1 is secreted through a non-classical, vesicle-mediated pathway by LPS-stimulated cells. (A) Confocal laser-scanning microscopy visualized
formation of YB-1–GFP-enriched vesicles in 2h after LPS stimulation of rMCs, however, this was not found for GFP-stimulation alone. Time-lapse
live-cell microscopy was carried out for over 120min with images taken every 2min (supplementary videos 1 and 2 online). (B) Biochemical
characterization of the YB-1 export mechanism was carried out with LPS-stimulated MM6 monocytic cells. Preincubation with brefeldin A as an
inhibitor of the classical export pathway enhances YB-1 secretion. Preincubation with inhibitors of ATP-binding cassette transporters (C) probenicid
and (D) glyburide reduces the release of YB-1. (E) The ionophore ionomycin superinduces LPS-dependent YB-1 secretion. (F) Disruption of the
electrochemical gradient by reserpine successfully blocks the LPS effect on YB-1 secretion. (G) Schematic drawing of the YB-1 domains and
distribution of 16 lysines (Ks) in the protein. (H) Expression plasmids for Flag–YB-1 and double-mutated Flag–YB-1 Lys301/304Ala proteins were
introduced into rMCs and equal expression levels were determined by Flag antibody. After LPS stimulation a time-dependent release of Flag–YB-1, but
not of mutated Flag–YB-1 (Lys301/304Ala), is detected with the supernatant (upper panels). Controls for cellular protein and precipitation efficiency
are provided in the lower panels. CSD, cold shock domain; GFP, green fluorescent protein; LPS, lipopolysaccharide; mm6, MonoMac-6; rMCs, rat
mesangial cells; YB, Y-box protein.
YB-1 is actively secreted through a non-classical pathway
B.C. Frye et al
&2009EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 10 | NO 7 | 2009
scientificreport
785(Fig 1E), and intravesicular YB-1 was protected from protease
digestion (trypsin), unless vesicles were solubilized by detergent
(Triton X-100) preincubation (Fig 1E). Contamination with other
cytosolic proteins was excluded, given the negative glyceral-
dehyde 3-phosphate dehydrogenase immunoblot. Furthermore,
successful vesicle enrichment was confirmed by anti-RAB7
western blot (Fig 1E). After the removal of vesicles by centrifuga-
tion, supernatants were analysed for YB-1 protein content. In fact,
TCA precipitation showed the presence of YB-1 in these super-
natants, indicating that after secretion vesicles disintegrate
and YB-1 becomes freely available in the extracellular milieu
(Fig 1E, sixth panel). Thus, monocytes stimulated by LPS release
YB-1 within vesicles. Trypsin-digest experiments ruled out that
YB-1 might have adhered non-specifically to the cytosolic side of
the vesicular membrane. Importantly, YB-1 secretion, stimulated
in a similar manner, was also observed in rat mesangial cells
(rMCs). Mesangial cells share phenotypic and functional
characteristics with monocytes (Mene ´ et al, 1989) and have
been shown to upregulate YB-1 under inflammatory conditions
(van Roeyen et al, 2005). Consequently, we observed that the
inflammation-related stimuli transforming growth factor-b and
hydrogen peroxide also resulted in vesicular secretion of
haemagglutinin-tagged YB-1 stably expressed in rMCs in a time-
and dose-dependent manner (supplementary Fig 2B–D online).
As, in this cell model, YB-1 was specifically detected through its
haemagglutinin tag, any cross-reactivity with other cold-shock
proteins could be excluded. Next, endogenous YB-1 release from
rMCs was tested. Both LPS and platelet-derived growth factor-BB
provoked a substantial release of YB-1 over a time range of
1–4h (supplementary Fig 1A online).
YB-1 is secreted by an alternative secretion mode
Using confocal laser-scanning microscopy, intracellular vesicle
formation with enriched levels of fluorescent YB-1–GFP (green
fluorescent protein) fusion protein was detected within 2h,
but not in control cells expressing GFP alone (Fig 2A; see also
live cell imaging in supplementary video online). These data hint
at a non-classical secretion mode for YB-1, bypassing the
endoplasmic reticulum and Golgi apparatus, as first described
by Rubartelli et al (1990) for interleukin-1b (IL-1b). For several
inflammatory mediators (IL-1b, MIF, HMGB1, thioredoxin 1 and
fibroblast growth factor 2), non-classical secretion has now been
verified (reviewed by Nickel, 2003). All these proteins lack an
amino-terminal signal-peptide sequence, which is required for
endoplasmic reticulum/Golgi targeting. In fact, computer-based
algorithms predict non-classical secretion of YB-1 and indicate
the absence of a canonical N-terminal signal peptide motif. To
investigate further the secretion mode of YB-1, we applied several
biochemical approaches. We first noticed that preincubation with
brefeldin A, which interferes with the classical secretion pathway,
did not reduce, but instead, increased, the secretion of YB-1
(Fig 2B), as shown earlier for other leaderless proteins such as
MIF and IL-1b (Rubartelli et al, 1990; Flieger et al, 2003). For
non-classically secreted proteins, different export machineries
have been described. For example, IL-1b and MIF secretion
depends on ABC transporters, as indicated by an inhibition of the
secretion of these mediators by glyburide or probenicid (Andrei
et al, 1999; Flieger et al, 2003). We tested whether glyburide and
probenicid would interfere with the secretion of YB-1. MM6 cells
were incubated with these agents before LPS stimulation. Both
glyburide and probenicid treatment resulted in a marked reduc-
tion of YB-1 secretion (Fig 2C,D). Protein exclusion of leaderless
proteins has been described to occur through vesicle formation;
for example, through exosomes, endolysosomes or microvesicle
shedding (Andrei et al, 1999; Gardella et al, 2002). To confirm
this question with respect to YB-1 secretion, we pursued two
pharmacological approaches: one using ionomycin, which is a
potent ionophore that induces degranulation in some cell types,
and the other using reserpine, which can disrupt secretion by
acting as an inhibitor of the ATP-dependent uptake of bioamines
into vesicles. Ionomycin was found to have a stimulatory effect on
the LPS-induced secretion of YB-1 (Fig 2E), whereas preincubation
of MM6 cells with reserpine strongly reduced YB-1 secretion
(Fig 2F), mirroring observations made earlier for IL-1b using similar
drugs (Andrei et al, 1999). It should be noted that non-specific
YB-1 release due to cell death was excluded in all experiments, as
indicated by the lack of measurable lactate dehydrogenase
release. Together, these results are in line with vesicle-mediated
YB-1 secretion. We next coexpressed GFP–RAB7 and dsRed–YB-1
in mesangial cells. Whereas in non-stimulated cells dsRed–YB-1 is
diffusely distributed throughout the cytosolic compartment, LPS
stimulation led to intravesicular accumulation of YB-1 and to a
notably partial, yet substantial, colocalization with GFP–RAB7
(supplementary Fig 3 online). This indicated that YB-1 secretion
occurred through the endolysosomal compartment.
Acetylation of HMGB1 is an essential step for protein
redistribution and its secretion (Bonaldi et al, 2003). YB-1 contains
16 lysine residues (Fig 2G). Two lysines at positions 301 and
304 at the carboxy-terminus of the protein are subject to
acetylation (data not shown). Exchange of these lysines by
alanines by using site-directed mutagenesis fully abrogates the
secretion of Flag-tagged YB-1, which is otherwise seen at 2h after
LPS addition (Fig 2H).
In summary, these results unanimously show that YB-1 is
secreted through an alternative secretion mode similar to
that observed for other leaderless proteins such as HMGB1,
IL-1b or MIF.
Extracellular YB-1 stimulates migration and proliferation
Extracellular occurrence of YB-1 raises the question of its
functional relevance. YB-1 orchestrates proliferation, for example
through DNA polymerase-a expression (Kohno et al, 2003; En-Nia
et al, 2005). Therefore, we studied the proliferative response of
different cell lines on stimulation with extracellular YB-1. rMCs as
well as human kidney 2 (HK-2) cells were assayed for their DNA
synthesis rates by using 5-bromodeoxyuridine incorporation.
Synchronized serum-depleted cells were stimulated with purified
rYB-1 (0.1mg/ml and 1mg/ml) or FCS (10% vol/vol, as a positive
control). Addition of rYB-1 increased the DNA synthesis rate
of both cell lines in a dose-dependent manner (supplementary
Fig 3A,B online). rYB-1 at 1mg/ml had a stimulatory effect of
90% (HK-2) and 40% (rMC), and the results were 35% and
60%, respectively, with FCS. Specificity of the pro-proliferative
effect of rYB-1 was underscored by blockade of the YB-1 effect
with a monoclonal YB-1 antibody (van Roeyen et al, 2005).
Similar results were obtained with breast epithelial cells of
cancerous (BT20) and non-cancerous (MCF12A) origin (data not
shown). Addition of YB-1 for 24h increased the proliferation rate
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Fig 3 |Extracellular YB-1 stimulates cell migration. (A) Rat mesangial cells grown to confluency and arrested by use of mitomycin C are assessed
for cell migration under different conditions for 48h. Increased migration in the scratched region is observed for cells stimulated with rYB-1 and
FCS (10%, positive control), whereas denatured YB-1 has no effect. (B) Quantification was carried out at four regions of the migration front in
three independent experiments. (C) Similarly, human mesangial cells (hMCs) show increased migration on stimulation with synthetic oligopeptides
corresponding to a YB-1 cold-shock domain motif compared with unstimulated cells, whereas the control peptide does not have any influence.
(D) These findings correlate to cytoskeletal changes in mesangial cells induced by YB-1 peptides, with a marked upregulation of actin stress fibres
within 1h, as detected by phalloidin staining. A. dest, Aqua dest; rMCs, rat mesangial cells; YB, Y-box protein.
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787of both cell lines to a similar degree as that achieved by the
addition of epidermal growth factor (EGF; positive control).
Denatured YB-1 had only a marginal influence on proliferation,
ruling out any effect because of endotoxin contamination of the
YB-1 preparation.
Besides mitotic events, cell motility is an important function
that relates to inflammatory processes with a turnover of matrix
and alterations of tissue architecture. Changes in proliferation as
well as motility were assessed in scratch-wound assays, in which
the cell monolayer is ‘injured’. Closure of this scratch was
significantly and dose-dependently inhibited by the addition
of monoclonal YB-1 antibody (supplementary Fig 3C online)
compared with isotype-matched control antibody, showing that
wound closure was dependent on YB-1.
In a reciprocal approach, mesangial cells were grown to
confluency and a scratch was introduced using a rubber police-
man. Mesangial cell migration was monitored by light microscopy
for 48h under non-stimulated conditions and after the addition of
rYB-1. Here, cell proliferation was blocked by the addition of
mitomycin C before cell stimulation to monitor cell migration
exclusively. rYB-1 markedly increased cell migration compared
with the basal migration rate under unstimulated conditions, to a
similar extent as observed with FCS (Fig 3A). This effect was
absent when denatured rYB-1 protein was used, excluding the
effects by LPS contaminants (Fig 3B). These results are reminiscent
of the findings using HMGB1, which induces cell migration in a
similar manner (Degryse et al, 2001). To address the question
whether full-length YB-1 or the subdomains confer them the
extracellular functions, oligopeptides (20 amino acids in length)
corresponding to various YB-1 epitopes were tested in similar
experiments. The biological activities of such short oligopeptides
have been shown before using fragments of amino-acyl transfer
RNA synthetases (Wakasugi & Schimmel, 1999). A peptide
corresponding to epitopes in the cold-shock domain significantly
induced cell migration in human mesangial cells (Fig 3C),
whereas a control peptide had no effect. Furthermore, the YB-1
peptide induced cytoskeletal changes of human mesangial cell
intracellular stress fibres. These findings are also in line with
observations made using HMGB1, which can induce stress fibres
in cells (Degryse et al, 2001).
In summary, extracellular YB-1 exerts a potent proliferative
response in different cell types and promotes cell migration.
Domains in the cold-shock protein probably mediate the effects,
as synthetic peptides mimic such functions. This raises the
question whether the observed protein fragments (compare
supplementary Figs 1 and 2 online) are functionally active.
Given the striking similarities between YB-1 secretion and
other non-classically secreted proteins of the nucleus (HMGB1
and heat-shock proteins), one might speculate that secretion of
highly conserved nuclear proteins reflects an evolutionarily
conserved mechanism to induce inflammation and cell activation.
METHODS
Cell culture systems and YB-1 secretion assay. The mesangial
cell YB-1 Tet-off system was established as described earlier
(Dooley et al, 2006). Peripheral blood monocytic cells (PBMCs)
were isolated by endotoxin-free Ficoll–Paque PLUS centrifugation
(Amersham) from healthy blood-donor buffy coats. Adherent
PBMCs cultured for 48h were used for the secretion assays.
Mesangial and MM6 cells were seeded at 3 105 cells per well
in six-well plates and the complete medium was replaced 12h
later with a serum-free RPMI medium supplemented with 10%
lipumine (PAA Laboratories). Stimulation was carried out, and the
conditioned medium was removed at the indicated time points.
Cells and debris were pelleted by centrifugation at 300g for 5min
at 371C. PBMC stimulation was carried out in RPMI medium
containing 0.5% FCS.
TCA precipitation and microvesicle preparation. Proteins were
precipitated by addition of TCA, (10% v/v, Sigma). Proteins
were precipitated by centrifugation at 20,000g for 45min at
41C, washed twice with ice-cold 70% ethanol, air-dried and
resuspended in 25ml distilled water.
Microvesicles were enriched by sequential centrifugation steps,
as depicted in supplementary Fig 2A online. Filters with 0.2mm
pore size (Nalgene) were used, followed by centrifugation at
100,000g. The resultant pellet (P2) was analysed for YB-1 content.
For the protease protection assay, the P2 fraction was resolved in
100ml PBS, 100ml PBS-CM with 0.1mg per 100ml trypsin or
100ml PBS-CM with 0.1mg per 100ml trypsin and 0.1% Triton
X-100, and was incubated for 60min.
Cell migration assay. The proliferative capacity of confluently
grown mesangial cells was blocked by mitomycin C (10mg/ml,
Sigma). A scratch was introduced on the cell layer and the
migratory front was assessed at four locations by using light
microscopy for 48h. Cells were incubated with full-length
native and denatured rYB-1 at the indicated concentrations for
peptides (see supplementary information online) or 10% FCS as
positive control.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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